DexCom
DXCM
Hutchmed (China)
HCM
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
4
Workday
WDAY
5
Dorian LPG
LPG
(Q1)Apr 4, 2025 | (FY)Jan 3, 2025 | (Q4)Jan 3, 2025 | (Q3)Sep 27, 2024 | (Q2)Jun 28, 2024 | (Q1)Mar 29, 2024 | (FY)Dec 29, 2023 | (Q4)Dec 29, 2023 | (Q3)Sep 29, 2023 | (Q2)Jun 30, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 6.46%355.03M | 1.39B | 352.84M | 8.46%359.12M | -13.03%348.49M | -16.60%333.47M | -8.63%1.46B | -18.63%332.5M | -19.08%331.12M | -1.47%400.72M |
Operating revenue | 6.46%355.03M | --1.39B | --352.84M | 8.46%359.12M | -13.03%348.49M | -16.60%333.47M | -8.63%1.46B | -18.63%332.5M | -19.08%331.12M | -1.47%400.72M |
Cost of revenue | 6.53%245.35M | 970.35M | 250.86M | 12.40%251.64M | -11.60%237.53M | -13.60%230.31M | -6.70%999.37M | -13.51%240.23M | -17.66%223.89M | 1.87%268.69M |
Gross profit | 6.32%109.68M | 423.58M | 101.98M | 0.24%107.48M | -15.95%110.96M | -22.61%103.16M | -12.52%464.81M | -29.50%92.26M | -21.88%107.23M | -7.64%132.03M |
Operating expense | 4.09%98.14M | 365.91M | 90.57M | 34.64%88.68M | 16.57%92.37M | 19.94%94.28M | 7.05%304.72M | 9.23%81.01M | -8.40%65.86M | 9.35%79.24M |
Selling and administrative expenses | 2.29%70.18M | --261.06M | --64.42M | 22.71%61.54M | 17.13%66.5M | 19.46%68.61M | 8.76%225.03M | 13.52%60.68M | -4.80%50.15M | 7.90%56.78M |
-Selling and marketing expense | 5.33%32.85M | --121.21M | --31.38M | 19.08%29.1M | 11.23%29.54M | 31.76%31.19M | 10.63%100.45M | 25.61%25.79M | 3.96%24.44M | 9.85%26.56M |
-General and administrative expense | -0.24%37.33M | --139.86M | --33.04M | 26.16%32.44M | 22.31%36.96M | 10.84%37.42M | 7.30%124.58M | 5.98%34.89M | -11.86%25.71M | 6.25%30.22M |
Research and development costs | 18.01%17.04M | --60.31M | --14.98M | 80.85%16.1M | -2.63%14.79M | -5.52%14.44M | -5.38%53.18M | -10.32%13.81M | -36.19%8.9M | 6.85%15.19M |
Depreciation amortization depletion | -2.82%10.92M | --44.53M | --11.17M | 62.06%11.04M | 52.30%11.08M | 90.59%11.24M | 23.09%26.51M | 22.62%6.53M | 29.18%6.81M | 29.12%7.28M |
-Depreciation and amortization | -2.82%10.92M | --44.53M | --11.17M | 62.06%11.04M | 52.30%11.08M | 90.59%11.24M | 23.09%26.51M | 22.62%6.53M | 29.18%6.81M | 29.12%7.28M |
Operating profit | 30.05%11.54M | 57.67M | 11.4M | -54.55%18.8M | -64.78%18.59M | -83.77%8.88M | -35.11%160.09M | -80.16%11.25M | -36.71%41.37M | -25.10%52.78M |
Net non-operating interest income expense | 2.96%-12.93M | -54.94M | -13.52M | -310.50%-14.23M | -213.83%-13.87M | -278.56%-13.33M | -116.13%-19.32M | -204.66%-7.92M | -29.96%-3.47M | -160.34%-4.42M |
Non-operating interest expense | -2.96%12.93M | --54.94M | --13.52M | 310.50%14.23M | 213.83%13.87M | 278.56%13.33M | 116.13%19.32M | 204.66%7.92M | 29.96%3.47M | 160.34%4.42M |
Other net income (expense) | -84,682.85%-261.98M | -1.72M | -2.17M | -48.06%456K | 158.02%311K | -1,187.50%-309K | 47.22%-2.11M | -161.70%-2.43M | -39.07%878K | 80.97%-536K |
Special income (charges) | ---262.13M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Less:Impairment of capital assets | --262.13M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | 148.54%150K | ---1.72M | ---2.17M | -48.06%456K | 158.02%311K | -1,187.50%-309K | 47.22%-2.11M | -161.70%-2.43M | -39.07%878K | 80.97%-536K |
Income before tax | -5,429.52%-263.37M | 1.01M | -4.29M | -87.03%5.03M | -89.47%5.04M | -109.31%-4.76M | -40.68%138.66M | -98.29%911K | -39.54%38.78M | -27.49%47.83M |
Income tax | -187.06%-3.64M | -5.5M | -4.11M | -92.82%250K | -104.58%-371K | -113.51%-1.27M | -37.45%17.82M | -1,520.81%-3.14M | -73.93%3.48M | -35.05%8.1M |
Net income | -7,329.46%-259.73M | 6.51M | -179K | -86.46%4.78M | -86.39%5.41M | -108.37%-3.5M | -41.13%120.85M | -92.35%4.05M | -30.49%35.29M | -25.73%39.74M |
Net income continuous Operations | -7,329.46%-259.73M | --6.51M | ---179K | -86.46%4.78M | -86.39%5.41M | -108.37%-3.5M | -41.13%120.85M | -92.35%4.05M | -30.49%35.29M | -25.73%39.74M |
Minority interest income | -40K | -38K | 0 | 0 | ||||||
Net income attributable to the parent company | -7,328.32%-259.69M | 6.55M | -141K | -86.46%4.78M | -86.39%5.41M | -108.37%-3.5M | -41.13%120.85M | -92.35%4.05M | -30.49%35.29M | -25.73%39.74M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | -7,328.32%-259.69M | 6.55M | -141K | -86.46%4.78M | -86.39%5.41M | -108.37%-3.5M | -41.13%120.85M | -92.35%4.05M | -30.49%35.29M | -25.73%39.74M |
Basic earnings per share | -7,687.50%-6.23 | 0.16 | 0 | -86.75%0.11 | -86.17%0.13 | -108.08%-0.08 | -41.15%2.86 | -92.00%0.1 | -30.83%0.83 | -25.98%0.94 |
Diluted earnings per share | -7,687.50%-6.23 | 0.16 | 0 | -86.75%0.11 | -86.17%0.13 | -108.16%-0.08 | -41.12%2.85 | -92.00%0.1 | -30.83%0.83 | -25.40%0.94 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |